TDSPharm Co

TDSPharm Co EBIT per Share

The EBIT per Share of TDSPharm Co (464280.KQ) as of Oct 24, 2026 is 711.96 KRW. In the previous year, EBIT per Share was 705.24 KRW — a change of 0.95% (higher).

EBIT per Share

711.96KRW

YoY

0.95%

Last updated:

EBIT per Share of TDSPharm Co is 2025 711.96 KRW. EBIT per Share of TDSPharm Co was 2024 705.24 KRW. It decreases by 0.95% higher compared to the previous year.

The TDSPharm Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
471.98 KRW
Jan 1, 2022
807.80 KRW
Jan 1, 2023
1,047.60 KRW
Jan 1, 2024
705.24 KRW
Jan 1, 2025
711.96 KRW
The TDSPharm Co EBIT per Share history
YEAREBIT per ShareYoY
711.96KRW+0.95%
705.24KRW-32.68%
1,047.60KRW+29.69%
807.80KRW+71.15%
471.98KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

TDSPharm Co Stock analysis

What does TDSPharm Co do? TDSPharm Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TDSPharm Co stock

EBIT per Share of TDSPharm Co is 711.96 KRW in 2025.

EBIT per Share of TDSPharm Co changed from 705.24 KRW to 711.96 KRW, representing a 0.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share TDSPharm Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — TDSPharm Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — TDSPharm Co